학술논문
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial
Document Type
Article
Author
Guigay, Joël ; Ortholan, Cécile; Vansteene, Damien; Cupissol, Didier; Even, Caroline; Kaminsky, Marie-Christine; Sire, Christian; Blot, Emmanuel; Debourdeau, Philippe; Bozec, Laurence; Saada-Bouzid, Esma; Fayette, Jérôme; Dalloz, Pierre; Pointreau, Yoann; Caer, Hervé Le; Falandry, Claire; Digue, Laurence; Braccini, Antoine; Lopez, Stéphane; Guillet, Pierre; Michel, Cécile; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cécile; Aupérin, Anne
Source
In The Lancet Healthy Longevity March 2024 5(3):e182-e193
Subject
Language
ISSN
2666-7568